What Role Should Genomic Classifier Testing Play in Prostate Cancer?

(MedPage Today) -- Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients with newly diagnosed prostate cancer considering first-line treatment, according to results from a...